封面
市場調查報告書
商品編碼
2056286

顧客忠誠度與轉換趨勢:抗體(2026)

2026 Customer Loyalty and Switching: Antibodies

出版日期: | 出版商: BioInformatics | 英文 86 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

報告摘要

研究人員對抗體供應商的忠誠度如何?哪些因素會導致他們更換供應商?哪些目錄抗體供應商在客戶滿意度和客戶客戶維繫領先?他們面臨的挑戰又在哪裡?

「顧客忠誠度與轉換趨勢-抗體(2026)」是一份權威報告,清楚展現了生命科學專業人士的現況。該報告基於來自北美、歐洲和亞太地區296位研究人員的反饋,為您的團隊提供所需的基準數據和市場信息,助力他們在抗體供應商市場中自信決策。

本報告分析了關鍵供應商指標,包括淨推薦值 (NPS)、複購意願、品牌親和性以及阻礙研究人員更換供應商的障礙。主要發現表明,賽默飛世爾科技 (Thermo Fisher Scientific)、Abcam 和 Cell Signaling Technologies (CST) 佔市場主導地位,大多數研究人員平均同時使用 5.6 家供應商。本報告指出了影響客戶忠誠度的因素,涵蓋產品品質和一致性、價格和可靠性等,同時重點介紹了小規模的供應商正在開闢競爭優勢的領域。

研究目標

  • 了解研究人員對抗體供應商的了解程度以及他們推薦這些供應商的意願。
  • 衡量供應商忠誠度,找出驅動忠誠度的主要原因。
  • 評估更換供應商的可能性,並確定促使更換供應商的因素。
  • 比較市場上不同供應商的消費者偏好。
  • 我們從產品品質、價格和產品範圍等關鍵指標評估供應商的表現。
  • 評估供應商特徵(產品範圍、品質、價格)與顧客忠誠度之間的關係。

提到的公司

本報告提及和/或評估以下供應商:對於主要抗體供應商,我們評估其當前使用情況、購買頻率、考慮程度、成為首選的可能性、再次購買意願、淨推薦值 (NPS)、感知品質、產品系列的廣度以及信任度、好感度和忠誠度。

  • Abcam
  • Abnova
  • Agilent(Dako)
  • Beckman Coulter
  • Bio-Rad(原名 AbD Serotec)
  • Bio-Techne(Novus Biologicals、R&D Systems、BiosPacific)
  • Cayman Chemical
  • Cell Signaling Technologies
  • Cytiva (Amersham)
  • Enzo Life Sciences
  • GenScript
  • Jackson ImmunoResearch Laboratories
  • MilliporeSigma/Merck(Calbiochem、Novagen、Sigma Aldrich)
  • Miltenyi Biotec
  • New England Biolabs
  • PROGEN
  • Promega
  • ProteinTech
  • Revvity(BioLegend)
  • Roche (Spring Bioscience, Ventana)
  • Rockland Immunochemicals
  • Santa Cruz Biotechnology
  • STEMCELL Technologies
  • 賽默飛世爾科技(eBioscience、Invitrogen、Lab Vision、Molecular Probes、PeproTech、Pierce)
  • Vector Laboratories
  • Waters Biosciences(前身為 BD Biosciences、Becton Dickinson Horizo​​n、Pharmingen 等)

目錄

  • 1. 研究概述與目標
  • 2.摘要整理
  • 3. 人口統計數據
  • 4. 生命科學領域人工智慧應用趨勢
  • 5. 對人工智慧的看法
  • 6. 人工智慧解決方案的商業提供商
  • 7. 目前工作流程整合
  • 8. 購買意願及影響因素
  • 9.調查方法
  • 10. 關於這家研究公司
簡介目錄
Product Code: 26-019BIO

Report Description

How loyal are researchers to their antibody suppliers, and what drives them to switch? Which catalog antibody providers lead in customer satisfaction and retention, and where do gaps exist?

The 2026 edition of Customer Loyalty and Switching: Antibodies delivers a definitive read on where life science professionals stand today. Drawing on responses from n=296 researchers across North America, Europe, and APAC, this report provides your team the benchmarks and market intelligence needed to act with confidence in the antibody supplier landscape.

This edition explores critical supplier metrics including Net Promoter Score, repurchase likelihood, brand affinity, and the barriers preventing researchers from switching suppliers. Key findings reveal that Thermo, Abcam, and Cell Signaling Technologies (CST) dominate the market, with most researchers using an average of 5.6 suppliers simultaneously. The report identifies which factors drive loyalty—from product quality and consistency to pricing and trustworthiness—and highlights where smaller suppliers are carving out competitive niches.

Study Objectives

  • Understand researcher familiarity with antibody suppliers and likelihood to recommend
  • Measure loyalty to suppliers and identify the key reasons driving loyalty
  • Gauge likelihood of switching suppliers and identify factors that drive switching behavior
  • Compare consumer preferences across suppliers in the market
  • Assess supplier performance across key metrics including product quality, pricing, and portfolio breadth
  • Evaluate the relationship between supplier characteristics (breadth, quality, price) and customer loyalty

Companies Mentioned

The following suppliers are mentioned and/or evaluated in this report. Current usage, frequency of purchase, consideration, first consideration, repurchase likelihood, net promoter score, perceptions of quality, portfolio breadth, and feelings of trust, want love, and loyalty are assessed for leading antibody suppliers.

  • Abcam
  • Abnova
  • Agilent (Dako)
  • Beckman Coulter
  • Bio-Rad (formerly AbD Serotec)
  • Bio-Techne (Novus Biologicals, R&D Systems, BiosPacific)
  • Cayman Chemical
  • Cell Signaling Technologies
  • Cytiva (Amersham)
  • Enzo Life Sciences
  • GenScript
  • Jackson ImmunoResearch Laboratories
  • MilliporeSigma/Merck (Calbiochem, Novagen, Sigma Aldrich)
  • Miltenyi Biotec
  • New England Biolabs
  • PROGEN
  • Promega
  • ProteinTech
  • Revvity (BioLegend)
  • Roche (Spring Bioscience, Ventana)
  • Rockland Immunochemicals
  • Santa Cruz Biotechnology
  • STEMCELL Technologies
  • Thermo Fisher Scientific (eBioscience, Invitrogen, Lab Vision, Molecular Probes, PeproTech, Pierce)
  • Vector Laboratories
  • Waters Biosciences (formerly BD Biosciences, Becton Dickinson Horizon, Pharmingen, etc.)

Table of Contents

  • 1.Study Overview and Objectives
  • 2.Executive Summary
  • 3.Demographics
  • 4.Trends in AI Adoption in the Life Sciences
  • 5.Perceptions of AI
  • 6.Commercial Providers of AI Solutions
  • 7.Current Workflow Integration
  • 8.Purchase Intent and Adoption Drivers
  • 9.Methodology
  • 10.About BioInformatics